Biotech

All Articles

James Wilson leaving behind Penn to launch two brand new biotechs

.After more than three decades, genetics treatment trendsetter James Wilson M.D., Ph.D., is leaving ...

3 biotechs attempt to beat the summertime warm through losing staff

.As biotechs try to turn a fresh web page in August, at the very least 3 companies have dropped team...

venBio lifts $528M for fifth lifestyle scientific researches VC fund

.Pro venture capital company venBio has actually elevated one more half a billion bucks to invest in...

Otsuka pays for $800M for Jnana and also its clinical-stage PKU medicine

.Otsuka Pharmaceutical has actually gotten Boston-based Jnana Therapeutics for $800 thousand so the ...

FibroGen gives up 75% of US team as asset flunks 2 even more trials

.FibroGen is actually significantly reorganizing its own service, giving up 75% of its own U.S. team...

Tracon relax weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has made a decision to unwind operations full weeks after an injectable immu...

Ideaya bags option on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...

Takeda takes $140M loss on stopped working epilepsy drug, touts FDA manage

.Our team actually recognize that Takeda is hoping to find a course to the FDA for epilepsy medicine...

VBI Injections files for personal bankruptcy, seeks resource purchase

.Immunology biotech VBI Injections is actually drifting precariously near the point of no return, al...

Celldex anti-cKIT antitoxin lower colonies in yet another stage 2 research study

.It is actually difficult to muscle in on a space as very competitive as immunology, however Celldex...